Latest news with #JenniferByrne
Business Wire
01-07-2025
- Health
- Business Wire
Javara, Cape Fear Valley Health Announce Partnership to Expand Point of Care Clinical Trial Access
WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Dedicated to expanding clinical trial access through collaboration with community-based healthcare systems, Javara today announced a new strategic partnership with Cape Fear Valley Health. Leveraging Javara's integrated teams and infrastructure, Cape Fear Valley Health — North Carolina's 8 th largest health system — will now offer clinical trial opportunities to their diverse patient population in Fayetteville, North Carolina and the surrounding areas. A multi-specialty health system with eight hospitals, an emerging medical school in partnership with Methodist University, and over 1,000 physicians, Cape Fear Valley Health currently serves eight counties in the southeastern portion of the state. Javara will employ and embed experienced clinical research staff within Cape Fear Valley Health clinics to work alongside their physicians and medical teams to scale trial operations and provide personalized care for patients electing to participate in clinical research. 'Cape Fear Valley's presence across North Carolina is vast. Their facilities and patient reach offer an unparalleled opportunity to improve population health through access to clinical trial participation,' said Javara Founder and CEO Jennifer Byrne. 'Through this partnership, we are driving forward a more inclusive clinical trial landscape — delivering access where it's needed most in the greater Fayetteville area and strengthening research efforts in oncology and beyond.' With prior research experience, Cape Fear Valley Health is perfectly positioned to maximize the impact of an integrated approach to trial delivery. Specialty and Therapeutic Capabilities will include Oncology, Cardiology, Neurology, Psychiatry, Pediatrics, Women's Health and Family Health. 'This collaboration with Javara restores a critical pathway for patients in our community to access clinical trials,' said Cape Fear Valley Health Chief Medical Officer Samual Fleishman, MD. 'Cape Fear Valley and Javara share a common goal to improve access to healthcare in underserved populations through clinical trials. This partnership enables us to again bring new interventions and cutting-edge treatments to our patients.' About Javara Javara, the leading Integrated Research Organization (IRO), partners with large healthcare organizations to deliver clinical trial access at the point of care through integrated research staff and infrastructure. The company's access to broad diverse patient populations through their trusted physician ensures clinical trials are completed with high enrollment and retention for quality data delivery. Javara's centralized resources and standardized operations provide efficiencies for accelerated study start-up and quality outcomes, so fewer obstacles stand in the way of the product approval process. As pioneers of Clinical Research as a Care Option (CRAACO), Javara is transforming healthcare and changing lives by connecting the right patients to the right trials at the right time. For more information, visit and follow the company on LinkedIn. About Cape Fear Valley Health System Cape Fear Valley Health is a 1,000+ bed, 8-hospital regional health system, with more than 1 million inpatient and outpatient visits annually. A private not-for-profit organization with 8,000 employees and more than 1,000 providers on our medical staff, it includes Cape Fear Valley Medical Center, Highsmith-Rainey Specialty Hospital, Cape Fear Valley Rehabilitation Center, Behavioral Health Care, Bladen County Hospital, Hoke Hospital, Health Pavilion North, Health Pavilion Hoke, Central Harnett Hospital and Betsy Johnson Hospital. For more information, visit
Yahoo
01-07-2025
- Health
- Yahoo
Javara, Cape Fear Valley Health Announce Partnership to Expand Point of Care Clinical Trial Access
WINSTON-SALEM, N.C., July 01, 2025--(BUSINESS WIRE)--Dedicated to expanding clinical trial access through collaboration with community-based healthcare systems, Javara today announced a new strategic partnership with Cape Fear Valley Health. Leveraging Javara's integrated teams and infrastructure, Cape Fear Valley Health — North Carolina's 8th largest health system — will now offer clinical trial opportunities to their diverse patient population in Fayetteville, North Carolina and the surrounding areas. A multi-specialty health system with eight hospitals, an emerging medical school in partnership with Methodist University, and over 1,000 physicians, Cape Fear Valley Health currently serves eight counties in the southeastern portion of the state. Javara will employ and embed experienced clinical research staff within Cape Fear Valley Health clinics to work alongside their physicians and medical teams to scale trial operations and provide personalized care for patients electing to participate in clinical research. "Cape Fear Valley's presence across North Carolina is vast. Their facilities and patient reach offer an unparalleled opportunity to improve population health through access to clinical trial participation," said Javara Founder and CEO Jennifer Byrne. "Through this partnership, we are driving forward a more inclusive clinical trial landscape — delivering access where it's needed most in the greater Fayetteville area and strengthening research efforts in oncology and beyond." With prior research experience, Cape Fear Valley Health is perfectly positioned to maximize the impact of an integrated approach to trial delivery. Specialty and Therapeutic Capabilities will include Oncology, Cardiology, Neurology, Psychiatry, Pediatrics, Women's Health and Family Health. "This collaboration with Javara restores a critical pathway for patients in our community to access clinical trials," said Cape Fear Valley Health Chief Medical Officer Samual Fleishman, MD. "Cape Fear Valley and Javara share a common goal to improve access to healthcare in underserved populations through clinical trials. This partnership enables us to again bring new interventions and cutting-edge treatments to our patients." About Javara Javara, the leading Integrated Research Organization (IRO), partners with large healthcare organizations to deliver clinical trial access at the point of care through integrated research staff and infrastructure. The company's access to broad diverse patient populations through their trusted physician ensures clinical trials are completed with high enrollment and retention for quality data delivery. Javara's centralized resources and standardized operations provide efficiencies for accelerated study start-up and quality outcomes, so fewer obstacles stand in the way of the product approval process. As pioneers of Clinical Research as a Care Option (CRAACO), Javara is transforming healthcare and changing lives by connecting the right patients to the right trials at the right time. For more information, visit and follow the company on LinkedIn. About Cape Fear Valley Health System Cape Fear Valley Health is a 1,000+ bed, 8-hospital regional health system, with more than 1 million inpatient and outpatient visits annually. A private not-for-profit organization with 8,000 employees and more than 1,000 providers on our medical staff, it includes Cape Fear Valley Medical Center, Highsmith-Rainey Specialty Hospital, Cape Fear Valley Rehabilitation Center, Behavioral Health Care, Bladen County Hospital, Hoke Hospital, Health Pavilion North, Health Pavilion Hoke, Central Harnett Hospital and Betsy Johnson Hospital. For more information, visit View source version on Contacts Media Contacts Brooke Kellybkelly@ Media Contact Chaka Jordancgjordan@ +1 910 615 6098 Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
The Guardian
17-06-2025
- Entertainment
- The Guardian
Helen Garner reflects on the ‘three worst weeks of my life' caring for a dying friend
When Helen Garner arrived at Sydney's Belvoir St theatre last Wednesday, she was worried the next two hours were 'going to be gruesome'. It was opening night of the adaptation of her 2008 novel, The Spare Room, based on her experience caring for a dying friend who came to stay with her. 'They were the three worst weeks of my life, they were just unforgettably dreadful,' Garner said in conversation with Jennifer Byrne at Belvoir on Monday evening. 'I came along [to opening night] feeling that I would find it unbearable to live those three weeks again.' After the show, she crawled into bed 'exhausted'. 'I don't sleep very well now, since I got old, but I got into bed and I slept without moving for nine hours,' Garner said. 'Seeing those three weeks played out on stage resolved something in me.' In The Spare Room, the narrator, Helen, gamely agrees to host her old friend Nicola when she flies from Sydney to Melbourne to attend a cancer clinic, without realising how close to death she is. As the novel opens, Helen is preparing her spare room for her friend – fresh sheets, plumped pillows, a new rug, flowers – confident in her capabilities as a hostess and carer. This is quickly punctured by Nicola's shocking frailty and poor health, and her irrational optimism about her prognosis and the clinic's dubious treatment protocol – which turns out to be Vitamin C injections and 'ozone baths'. There follows a power struggle: Helen's fierce love for her friend gives way to excoriating rage at her delusional positivity and refusal to admit she's dying, while Nicola stubbornly resists Helen's attempts to arrange proper pain medication and palliative care. 'I was cruel to her,' Garner confessed, reflecting on her experience with her friend (Jenya Osborne, who died in 2006), adding: 'When somebody's in a trance of craziness, you want to snap them out of it – and that can make you cruel, harsh.' Belvoir's artistic director, Eamon Flack, who adapted the novel for stage, said it was Garner's frank depiction of an older woman's rage that drew him to it. Garner said she was criticised for precisely this aspect of her novel when it was first published. 'Quite a few older men criticised it because they said it was too full of anger … I was kind of shocked, actually, [because] we rage against death; there's a lot of anger in us when death is in the room.' These criticisms upset her, she admitted. 'You don't want to [be seen as] 'Oh, you're so angry.' 'Why are you so angry, Helen? You're always angry' – that's something people [have said]. Even my grandson said this to me the other day: 'Hel, you're full of anger,'' she said, rearing back in mock rage: 'I said, 'How dare you!'' Not a single woman has criticised The Spare Room for its anger, Garner said; instead, many older women thanked her for depicting the carer's experience. One full-time carer told her: 'Helen, we all feel that anger. We're all tormented by it. Don't be ashamed of it. It's part of the whole thing. You have to go there.' In Belvoir's adaptation, Helen is portrayed by stage and screen veteran Judy Davis – a performance that Garner said she found 'shattering' to watch. 'But it took me a moment to get used to it,' she said. 'I don't go to the theatre much any more. I used to go a lot – I even used to be a theatre critic in the 80s – but now I just look at movies and stuff on TV. And I'd forgotten how actory [theatre] actors are. There's such a lot of big gestures, big movements, and I thought, 'Oh my God, could you just stand still for a moment?' … I kept saying 'I would never do that. I would never run across the room like that'.' Garner said she is not generally a fan of adaptations of her work – but neither does she feel the need to be heavily involved. 'I'm happy to hand stuff over,' she said. 'I wouldn't have wanted to have anything to do with this production … I would feel that I was useless.' One exception was Ken Cameron's 1982 film adaptation of her 1977 novel, Monkey Grip, where she happened to be on set the day they were filming a scene between Noni Hazlehurst and Colin Friels after his character had overdosed. 'He says 'Sorry, Nora', and in the book she says, 'You don't have to say that' – and so Noni [said the line] and I said, 'CUT! That's so wrong. She's in a rage.' But they were going to play it in this soppy, wet [way],' Garner said. 'I'm always glad that I was there.' When Byrne said she would like to see all of Garner's books adapted for stage, Garner retorted with characteristic frankness: 'I'm telling you now, I would hate that. I mean, God, there's so much shit in there.' The audience laughed appreciatively – but the author fixed us with a gimlet eye. 'And when I die, don't think anybody's gonna get in it then, either.' The Spare Room is at Belvoir St theatre, Sydney until 13 July
Business Wire
28-05-2025
- Business
- Business Wire
Javara Secures Series C Funding To Drive Therapeutic Expansion For Community-Forward Clinical Research
WINSTON-SALEM, N.C.--(BUSINESS WIRE)-- Javara, a leading integrated research organization (IRO) delivering clinical trials at the point of care through strategic partnership with healthcare organizations, today announced it has secured a significant growth investment in Series C funding from earlier and new community-based investors. This funding will support the expansion of both current and new healthcare partnerships and allow the company to grow into new therapeutic specialties such as Oncology, CNS, and Neurology through localized clinical research collaborations that increase patient access and amplify geographic footprint. Established in 2018, Javara was built with a vision to revolutionize the industry by accelerating access to research – for patients, biopharma companies and healthcare organizations alike. Founders Jennifer Byrne, Linda McCarty, and Amanda Wright say this funding is an essential next step in driving that mission forward. Javara's current access includes over 5 million patients across 7 states. The organization now faces the opportunity to double both patient and physician reach and develop new areas of therapeutic excellence that parallel current primary public health concerns and the rapid evolution of the clinical trials industry. 'We are extremely grateful for the privilege and opportunity this funding secures as we move into an accelerated growth era for Javara,' said Javara Founder and CEO Jennifer Byrne. 'The support of a broadened group of community-based investors will amplify our impact greatly as we work to deliver community-based clinical trial access and education for more patients across the nation.' Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan advised Javara on the Series C funding round. Crosstree Capital Partners acted as an advisor to Javara. About Javara: Javara, the leading Integrated Research Organization (IRO), partners with large healthcare organizations to deliver clinical trial access at the point of care through integrated research staff and infrastructure. The company's access to broad diverse patient populations through their trusted physician ensures clinical trials are completed with high enrollment and retention for quality data delivery. Javara's centralized resources and standardized operations provide efficiencies for accelerated study start-up and quality outcomes, so fewer obstacles stand in the way of the product approval process. As pioneers of Clinical Research as a Care Option (CRAACO), Javara is transforming healthcare and changing lives by connecting the right patients to the right trials at the right time.
